Pascal Andre Stein

Person

Boston, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Methods of use of anti-CD19 antibodies with reduced immunogenicity
- Patent number 10,072,092
- Issue date Sep 11, 2018
- Merck Patent GmbH
- Michael Super
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods of treating cancer using interleukin-12p40 variants having...
- Patent number 9,029,330
- Issue date May 12, 2015
- Merck Patent GmbH
- Gordon D. Webster
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-CD19 antibodies with reduced immunogenicity
- Patent number 8,957,195
- Issue date Feb 17, 2015
- Merck Patent GmbH
- Michael Super
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody fusion proteins with a modified FcRn binding site
- Patent number 8,907,066
- Issue date Dec 9, 2014
- Merck Patent GmbH
- Kin-Ming Lo
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-CD19 antibodies with reduced immunogenicity
- Patent number 8,691,952
- Issue date Apr 8, 2014
- Merck Patent GmbH
- Michael Super
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Nucleic acids encoding interleukin-12P40 variants with improved sta...
- Patent number 8,188,248
- Issue date May 29, 2012
- Merck Patent GmbH
- Gordon D. Webster
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
DNA encoding IL-2 fusion proteins with modulated selectivity
- Patent number 7,888,071
- Issue date Feb 15, 2011
- Merck Patent GmbH
- Stephen D. Gillies
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Interleukin-12p40 variants with improved stability
- Patent number 7,872,107
- Issue date Jan 18, 2011
- Merck Patent GmbH
- Gordon D. Webster
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cancer treatments including administering IL-2 fusion proteins with...
- Patent number 7,462,350
- Issue date Dec 9, 2008
- EMD Serono Research Center, Inc.
- Stephen D. Gillies
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
IL-2 fusion proteins with modulated selectivity
- Patent number 7,186,804
- Issue date Mar 6, 2007
- EMD Lexigen Research Center Corp.
- Stephen D. Gillies
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
METHODS OF USE OF ANTI-CD19 ANTIBODIES WITH REDUCED IMMUNOGENICITY
- Publication number 20150322159
- Publication date Nov 12, 2015
- Merck Patent GmbH
- Michael Super
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Antibody Fusion Proteins with a Modified FcRn Binding Site
- Publication number 20150274797
- Publication date Oct 1, 2015
- Merck Patent GmbH
- Kin-Ming Lo
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-CD19 ANTIBODIES WITH REDUCED IMMUNOGENICITY
- Publication number 20140288288
- Publication date Sep 25, 2014
- Merck Patent GmbH
- Michael Super
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Interleukin-12 P40 Variants with Improved Stability
- Publication number 20130034518
- Publication date Feb 7, 2013
- Merck Patent GmbH
- Gordon D. Webster
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INTERLEUKIN-12P40 VARIANTS WITH IMPROVED STABILITY
- Publication number 20110097792
- Publication date Apr 28, 2011
- Merck Patent GmbH
- Gordon D. Webster
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Antibody Fusion Proteins with a Modified FcRn Binding Site
- Publication number 20100272720
- Publication date Oct 28, 2010
- Merck Patent GmbH
- Kin-Ming Lo
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IL-2 FUSION PROTEINS WITH MODULATED SELECTIVITY
- Publication number 20090098609
- Publication date Apr 16, 2009
- Merck Patent GmbH
- Stephen D. Gillies
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Anti-CD19 antibodies with reduced immunogenicity
- Publication number 20070154473
- Publication date Jul 5, 2007
- Merck Patent GmbH
- Michael Super
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Interleukin-12p40 variants with improved stability
- Publication number 20070154453
- Publication date Jul 5, 2007
- Merck Patent GmbH
- Gordon D. Webster
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compositions and methods for treating tumors presenting survivin an...
- Publication number 20070104689
- Publication date May 10, 2007
- Merck Patent GmbH
- Stephen D. Gillies
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IL-2 fusion proteins with modulated selectivity
- Publication number 20070036752
- Publication date Feb 15, 2007
- EMD Lexigen Research Center Corp.
- Stephen D. Gillies
- C07 - ORGANIC CHEMISTRY

Pascal Andre Stein

Person

Patents Grantslast 30 patents

Methods of use of anti-CD19 antibodies with reduced immunogenicity

Methods of treating cancer using interleukin-12p40 variants having...

Anti-CD19 antibodies with reduced immunogenicity

Antibody fusion proteins with a modified FcRn binding site

Anti-CD19 antibodies with reduced immunogenicity

Nucleic acids encoding interleukin-12P40 variants with improved sta...

DNA encoding IL-2 fusion proteins with modulated selectivity

Interleukin-12p40 variants with improved stability

Cancer treatments including administering IL-2 fusion proteins with...

IL-2 fusion proteins with modulated selectivity

Patents Applicationslast 30 patents

METHODS OF USE OF ANTI-CD19 ANTIBODIES WITH REDUCED IMMUNOGENICITY

Antibody Fusion Proteins with a Modified FcRn Binding Site

ANTI-CD19 ANTIBODIES WITH REDUCED IMMUNOGENICITY

Interleukin-12 P40 Variants with Improved Stability

INTERLEUKIN-12P40 VARIANTS WITH IMPROVED STABILITY

Antibody Fusion Proteins with a Modified FcRn Binding Site

IL-2 FUSION PROTEINS WITH MODULATED SELECTIVITY

Anti-CD19 antibodies with reduced immunogenicity

Interleukin-12p40 variants with improved stability

Compositions and methods for treating tumors presenting survivin an...

IL-2 fusion proteins with modulated selectivity